Overview

A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's Sarcoma

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
This is a pilot study to determine the efficacy, kinetics and safety of aldoxorubicin in HIV positive subjects with Kaposi's sarcoma.
Phase:
Phase 2
Details
Lead Sponsor:
CytRx
Treatments:
Doxorubicin